Printer Friendly | Text Size

Abbott's Commitment in HIV/AIDS

For more than 20 years, Abbott has helped develop innovative HIV medicines and tests which have impacted countless lives worldwide.

Programs & support services

Philanthropic Results in Developing Countries
Abbott Fund Philanthropic AIDS Programs
Intellectual Property

Reports and Statements

HIV-related Reports and Position Papers
EMEA Approves New Heat-Stable Norvir® (ritonavir) Tablet

Important Product Information

Kaletra (lopinavir/ritonavir

U.S. Prescribing Information
Important Safety Information

Norvir (ritonavir)

U.S. Prescribing Information
Important Safety Information

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.